Secondary Logo

Institutional members access full text with Ovid®

Transcatheter aortic valve replacement

Karycki, Melody K., BSN, RN, CCRN

doi: 10.1097/01.CCN.0000549626.91064.0c

Abstract: Transcatheter aortic valve replacement (TAVR) is indicated in some patients with severe aortic stenosis for whom surgical intervention is not deemed appropriate. This article explores when TAVR may be the preferred treatment option over surgical aortic valve replacement and discusses various prosthetic valve devices. There are several FDA-approved prosthetic valve devices used in clinical practice including: balloon-expandable devices (SAPIEN 3, SAPIEN, and SAPIEN XT), self-expanding devices (Evolut R, Evolut PRO, ACURATE Neo, Portico, and Allegra), and mechanically expandable devices such as the LOTUS, which is currently unavailable as the delivery system is being refined.1 Additionally, TAVR diagnostic screenings, procedure, complications, postoperative management, and nursing considerations are also outlined.

Transcatheter aortic valve replacement (TAVR) is an alternative to surgical intervention. This article discusses various prosthetic valve devices and outlines TAVR diagnostic screening, procedures, complications, postoperative management, and nursing considerations.

Melody K. Karycki is a clinical nurse on the cardiovascular ICU at Baptist Medical Center, Jacksonville, Fla. She is also a student in the DNP program at the University of North Florida, Jacksonville, Fla.

The author has disclosed no financial relationships related to this article.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved